BioSpace News Archive

Policy

BioMarin Submits Marketing Authorization Application to European Medicines Agency for Valoctocogene Roxaparvovec to Treat Severe Hemophilia A

1st Marketing Application Submission for Gene Therapy Directed at Any Type of Hemophilia

November 21, 2019
·
6 min read
Deals

Exactech Expands Global Direct Operations with Acquisition of Italian Distributor

The purchase included all shares of the Province of Brescia-based importer and distributor of Exactech’s orthopaedic implants, instrumentation and advanced surgical technologies.

November 21, 2019
·
2 min read
Business

Medcolcanna expands Global Leadership Team with Appointment of Chief Corporate Development Officer

Pursuant his employment agreement executed on November 19, 2019, and subject to applicable regulatory and stock exchange approvals, he will be issued shares in the capital of the Company, at a deemed price of the closing price of the shares of the Company on that date.

November 21, 2019
·
4 min read
BioMidwest

Centene Corporation Prices Offering of Senior Notes

The Additional 2025 Notes will initially constitute a separate series of notes from the Existing 2025 Notes, but the Company has agreed to exchange the Additional 2025 Notes for additional Existing 2025 Notes, subject to certain conditions.

November 21, 2019
·
12 min read
Lone Star Bio

CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option

The additional shares were sold at the IPO price of $4.00 per share, before underwriting discounts and commissions.

November 21, 2019
·
2 min read
Novelion Therapeutics Provides Updates on Voluntary Liquidation and Other Matters

At the Company’s 2019 Annual General Meeting held November 5, 2019, shareholders voted in favor of all proposals contained in the Company’s proxy statement dated October 3, 2019

November 21, 2019
·
8 min read
Azeria Therapeutics Announces £32.0 million Series B Financing

Azeria Therapeutics (Azeria), a newly formed pioneer factor drug discovery company, today announced a £32 million Series B financing in which Syncona has committed £29.5 million alongside existing investor the CRT Pioneer Fund.

November 21, 2019
·
5 min read
Business

Patterson Companies Second-Quarter Fiscal 2020 Conference Call Scheduled for Thursday, December 5, 2019

The company’s earnings release will be issued that morning before the market opens.

November 21, 2019
·
1 min read
Business

Willow Biosciences Reports Third Quarter 2019 Results and Provides Operations Update

Willow Biosciences Inc. has released its financial and operating results for the three and nine months ended September 30, 2019.

November 21, 2019
·
9 min read
Policy

ENA-Supported Workplace Violence Bill Passed by House of Representatives

The U.S. House of Representatives on Thursday made a definitive statement of support for the safety of health care workers when it voted to approve The Workplace Violence Prevention for Health Care and Social Services Act of 2019 – a bill strongly backed by the Emergency Nurses Association..

November 21, 2019
·
3 min read